TITLE

Management of the no-reflow phenomenon

AUTHOR(S)
Margetić, Eduard
PUB. DATE
March 2013
SOURCE
Cardiologia Croatica;Mar/Apr2013, Vol. 8 Issue 3/4, p119
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion strategy for treating acute ST-segment elevation myocardial infarction (STEMI). The main goals are to restore epicardial infarct-related artery (IRA) patency and achieve microvascular reperfusion as early as possible, thus limiting the extent of irreversibly injured myocardium. Unfortunately, in many patients myocardial perfusion remains poor despite the successful restoration of IRA patency. The lack of adequate myocardial perfusion of a given coronary segment after prolonged ischemia without angiographic evidence of mechanical vessel obstruction is termed. It is clinically important as it is independently associated with increased occurrence of malignant arrhythmias, heart failure, in-hospital and long-term mortality. After the onset of STEMI an efficient emergency system that reduces ischaemic time is crucial for no-reflow prevention in patients undergoing PPCI. The risk of distal embolization is related to thrombus burden, which may be reduced by the use of glycoprotein IIb/IIIa inhibitors. The most potent endogenous mechanism to limit infarction is ischaemic preconditioning. Among patients undergoing PPCI thrombus aspiration has an emerging role. Other pharmacological agents (calcium channel blockers, sodium nitroprusside, adenosine, nicorandil) show promise for reduction of no reflow but require validation in larger, randomized trials. In conclusion, to improve clinical outcomes of STEMI we need to focus on increasing microvascular flow to ischaemic (but not infarcted) myocardium and reducing ischaemia-reperfusion injury. No reflow is a multifactorial process, so it is unlikely that one treatment will prevent or cure the process. Thus, prophylactic vasodilator therapy, mechanical devices, ischaemic preconditioning and potent platelet inhibitors in combination are more likely to be effective than any of these alone.
ACCESSION #
86888908

 

Related Articles

  • Inhibition of sPLA2-IIA, C-reactive Protein or Complement: New Therapy for Patients with Acute Myocardial Infarction? Krijnen, Paul A. J.; Meischl, Christof; Nijmeijer, Remco; Visser, Cees A.; Hack, C. Erik; Niessen, Hans W. M. // Cardiovascular & Haematological Disorders - Drug Targets;Jun2006, Vol. 6 Issue 2, p111 

    Reperfusion of ischemic myocardium after acute myocardial infarction (AMI) induces a local activation of inflammatory reactions that results in ischemia/reperfusion (I/R)-injury. I/R-injury contributes considerably to the total cell damage in the heart after AMI. Secretory phospolipase A2-IIA...

  • Reduction of infarct size by gentle reperfusion without activation of reperfusion injury salvage kinases in pigs. Musiolik, Judith; Caster, Patrick van; Skyschally, Andreas; Boengler, Kerstin; Gres, Petra; Schulz, Rainer; Heusch, Gerd // Cardiovascular Research;Jan2010, Vol. 85 Issue 1, p110 

    Aims: Reperfusion is mandatory to salvage ischaemic myocardium from infarction, but also induces additional reperfusion injury and contributes to infarct size (IS). Gentle reperfusion (GR) has been proposed to attenuate reperfusion injury, but this remains contentious. We now investigated...

  • Reactive Oxygen Species in Myocardial Reperfusion Injury: From Physiopathology to Therapeutic Approaches. Braunersreuther, Vincent; Jaquet, Vincent // Current Pharmaceutical Biotechnology;Jan2012, Vol. 13 Issue 1, p97 

    Myocardial ischemia is a major cause of morbidity and mortality in the world. Although restoration of blood flow after prolonged ischemia is essential for cardiomyocytes salvation and to limit myocardial damage and cardiac dysfunction, reperfusion itself exacerbates myocardial injury....

  • Mitochondrial DNA deletions in coronary artery bypass grafting patients Levitsky, Sidney; Laurikka, Jari; Stewart, Robert D.; Campos, Christian T.; Lahey, Steven J.; McCully, James D. // European Journal of Cardio-Thoracic Surgery;Nov2003, Vol. 24 Issue 5, p777 

    Objective: Mitochondrial DNA (mitoDNA) deletions have been shown to increase with aging and ischemia and have been suggested to contribute to myocardial dysfunction. The purpose of this study was to determine the prevalence and specificity of mitoDNA deletions in coronary artery bypass patients....

  • Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium. Karlsson, J. O. G.; Brurok, H.; Eriksen, M.; Towart, R.; Toft, K. G.; Moen, O.; Engebretsen, B.; Jynge, P.; Refsum, H. // Acta Radiologica;Nov2001, Vol. 42 Issue 6, p540 

    AbstractPurpose: To evaluate whether manganese dipyridoxyl diphosphate (MnDPDP) or its metabolite manganese dipyridoxyl ethyldiamine (MnPLED) reduces post-ischemic myocardial injury. Material and Methods: Left anterior descending artery (LAD) in anesthetized pigs was occluded (30 min) followed...

  • Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction. Sörensson, Peder; Rydén, Lars; Saleh, Nawsad; Tornvall, Per; Arheden, Håkan; Pernow, John // BMC Cardiovascular Disorders;2013, Vol. 13 Issue 1, p1 

    Background: Ischemic postconditioning (PostC), reperfusion in brief cycles, is known to induce short-term reduction in infarct size in patients with ST elevation myocardial infarction (STEMI), especially among those with large myocardium at risk (MaR). The aim of the present study was to...

  • The first minutes of reperfusion: a window of opportunity for cardioprotection Piper, H.M.; Abdallah, Y.; Schäfer, C. // Cardiovascular Research;Feb2004, Vol. 61 Issue 3, p365 

    During the past decade, the understanding has grown that control of the conditions of reperfusion is critical for salvaging ischemic–reperfused myocardium. The first few minutes of reperfusion constitute a critical phase, as here lethal tissue injury in addition to that already developed...

  • Hypothermia during reperfusion does not reduce myocardial infarct size in pigs. Maeng, Michael; Mortensen, Ulrik M.; Kristensen, Jens; Kristiansen, Steen B.; Andersen, Henning R. // Basic Research in Cardiology;Jan2006, Vol. 101 Issue 1, p61 

    We previously described a method for regional myocardial cooling that reaches the target temperature within 4 min. The present study evaluated whether this method for regional myocardial cooling during reperfusion reduces myocardial infarct size (IS) in 75–kg pigs. Myocardial infarction...

  • Salvia miltiorrhiza treatment during early reperfusion reduced postischemic myocardial injury in the rat. Ruqiong Nie; Rui Xia; Xingwu Zhong; Zhengyuan Xia // Canadian Journal of Physiology & Pharmacology;Oct2007, Vol. 85 Issue 10, p1012 

    Oxidative stress may play a causative role in myocardial ischemia�reperfusion injury. However, it is a relatively understudied aspect regarding an optimal timing of antioxidant intervention during ischemia�reperfusion. The present study investigates the effect of different treatment...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics